ILMN · Illumina, Inc.
$219.78
+6.54 (+3.07%)
At close · Aug 21
Market Cap
$33.04B
Shares
151.00M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jacob Thaysen | Chief Executive Officer | $11,018,895 |
| Everett Cunningham | Former Chief Commercial Officer | $4,087,101 |
| Ankur Dhingra | Chief Financial Officer | $4,078,071 |
| Steve Barnard | Chief Technology Officer | $3,480,152 |
| Kevin Pegels | Chief of Global Operations | $3,180,020 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jacob Thaysen | Chief Executive Officer | $14,802,924 |
| Everett Cunningham | Chief Commercial Officer | $10,073,818 |
| Ankur Dhingra | Chief Financial Officer | $5,856,087 |
| Charles Dadswell | Former General Counsel & Secretary | $4,517,203 |
| Joydeep Goswami | Former Chief Financial Officer, Chief Strategy and Corporate Development Officer | $4,243,761 |
| Steve Barnard | Chief Technology Officer | $4,020,936 |
| Kevin Pegels | Chief of Global Operations | $3,849,842 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Francis deSouza | Former Chief Executive Officer | $14,494,506 |
| Susan Tousi | Former Chief Commercial Officer | $5,334,653 |
| Joydeep Goswami | Former Chief Financial Officer, Chief Strategy and Corporate Development Officer | $5,314,177 |
| Alex Aravanis | Former Chief Technology Officer, Head of Research and Product Development | $5,069,310 |
| Jacob Thaysen | Chief Executive Officer | $4,691,233 |
| Phil Febbo | Former Chief Medical Officer | $4,526,469 |
| Charles Dadswell | Former General Counsel & Secretary | $4,139,866 |
| Kathryne Reeves | Former Chief Marketing Officer | $3,798,535 |
| Carissa Rollins | Chief Information Officer | $2,928,969 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Francis deSouza | Former Chief Executive Officer | $26,752,197 |
| Susan Tousi | Former Chief Commercial Officer | $8,790,558 |
| Alex Aravanis | Former Chief Technology Officer, Head of Research and Product Development | $8,747,014 |
| Phil Febbo | Former Chief Medical Officer | $4,722,318 |
| Joydeep Goswami | Former Chief Financial Officer, Chief Strategy and Corporate Development Officer | $3,537,626 |
| Charles Dadswell | Former General Counsel & Secretary | $3,477,849 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Robert Ragusa | Former Chief Operations Officer | $22,885,222 |
| Francis deSouza | Former Chief Executive Officer | $14,333,634 |
| Alex Aravanis | Former Chief Technology Officer, Head of Research and Product Development | $5,051,507 |
| Susan Tousi | Former Chief Commercial Officer | $5,041,489 |
| Charles Dadswell | General Counsel & Secretary | $3,561,286 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Francis A. deSouza | Chief Executive Officer; Director | $11,733,593 |
| Francis deSouza | Chief Executive Officer; Director | $11,733,593 |
| Alex Aravanis | Chief Technology Officer, Head of Research and Product Development | $5,416,844 |
| Mark Van Oene | Former Chief Commercial Officer | $3,245,633 |
| Susan Tousi | Chief Commercial Officer | $3,155,422 |
| Sam Samad | Chief Financial Officer | $2,466,176 |
| Sam A. Samad | Chief Financial Officer | $2,466,176 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Joydeep Goswami | Senior Vice President, Corporate Development and Strategic Planning | $1,984,825 |
| Francis A. deSouza | Chief Executive Officer; Director | $1,521,949 |
| Francis deSouza | Chief Executive Officer; Director | $1,521,949 |
| Aimee Hoyt | Senior Vice President & Chief People Officer | $864,073 |
| Omead Ostadan | Chief Product and Marketing Officer | $744,101 |
| Sam Samad | Chief Financial Officer | $626,703 |
| Sam A. Samad | Chief Financial Officer | $626,703 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Francis deSouza | CEO | $11,067,566 |
| Francis A. deSouza | Chief Executive Officer; Director | $11,067,566 |
| Omead Ostadan | Chief Product and Marketing Officer | $4,716,935 |
| Aimee Hoyt | Senior Vice President & Chief People Officer | $3,857,171 |
| Sam A. Samad | Chief Financial Officer | $2,897,197 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Francis deSouza | CEO | $8,807,716 |
| Francis A. deSouza | President and CEO; Director | $8,807,716 |
| Omead Ostadan | Chief Product and Marketing Officer | $3,453,544 |
| Sam A. Samad | Senior Vice President and Chief Financial Officer | $3,290,350 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Daniel M. Skovronsky, M.D., Ph.D. | Director | Appointed | 2026-06-23 |
| Gary S. Guthart | director | Retired | 2026-04-02 |
| Robert S. Epstein | director | Retired | 2026-04-02 |
| Frances Arnold | director | Retired | 2026-04-02 |
| Eric D. Green, M.D., Ph.D. | Chief Medical Officer (CMO) | Appointed | 2026-01-08 |
| Everett Cunningham | Chief Commercial Officer | Resigned | 2026-01-08 |
| Scott Gottlieb | non-executive Chair | Appointed | 2025-03-25 |
| Keith A. Meister | director | Appointed | 2025-03-25 |
| Stephen P. MacMillan | director | Resigned | 2025-03-25 |
| Carissa Rollins | Chief Information Officer | Retired | 2025-03-24 |
| Scott Davies | Interim General Counsel and Secretary | Appointed | 2024-10-03 |
| Ankur Dhingra | Chief Financial Officer | Appointed | 2024-04-09 |
| Jacob Thaysen | member of the Board | Appointed | 2023-09-05 |
| Jacob Thaysen | Chief Executive Officer | Appointed | 2023-09-05 |
| Steve Barnard | Chief Technology Officer | Appointed | 2023-08-09 |
| Charles Dadswell | interim Chief Executive Officer | Appointed | 2023-06-13 |
| Francis deSouza | director | Resigned | 2023-06-13 |
| Francis deSouza | Chief Executive Officer | Resigned | 2023-06-13 |
| Scott B. Ullem | Board member (member of the Audit Committee) | Appointed | 2023-06-07 |
| Stephen P. MacMillan | non-executive Chair of the Board | Appointed | 2023-06-07 |
| Andrew J. Teno | director | Appointed | 2023-05-30 |
| Gary S. Guthart, Ph.D. | director | Appointed | 2023-05-30 |
| Scott Gottlieb, M.D. | director | Appointed | 2023-05-30 |
| Philip W. Schiller | director | Appointed | 2023-05-30 |
| Susan E. Siegel | director | Appointed | 2023-05-30 |
Key facts
CIK
1110803
CUSIP
452327109
13F (30d)
821 filings
790 filers
Visit website
Investor relations